DXCM | DexCom, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	87.56 - 89.87
52 Week Range	62.34 - 142.00
Beta	1.22
Implied Volatility	33.65%
IV Rank	7.58%
Day's Volume	3,491,472
Average Volume	3,497,208
Shares Outstanding	390,772,000
Market Cap	34,692,738,160
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2005-04-14

Valuation
Profitability
Growth
Health
P/E Ratio	62.52
Forward P/E Ratio	149.51
EPS	1.42
1YR Price Target	120.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	9,500
Country	USA
Website	DXCM

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem.

DXCM's peers: ALGN, BIO, BSX, TNDM, INSP, SWAV, PEN, PODD, IART, SENS, EW, INMD, MDT, ABT, ZBH, MASI, MASS, NNOX, QDEL, SYK

*Chart delayed

Analyzing fundamentals for DXCM we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is very wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see DXCM Fundamentals page.

Watching at DXCM technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on DXCM Technicals page.